Shattuck Labs, Inc.: Deep Track Capital, LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Deep Track Capital, LP amended its Schedule 13G stake filing for Shattuck Labs, Inc., disclosing the change to the SEC under accession number 0001172661-26-005079. The filing is a passive-investor ownership update rather than an activist position, and it signals a shift in the fund's reported holding in the clinical-stage biotech. Investors should watch for the specific share count and percentage disclosed in the amendment, since 13G filings are typically tied to thresholds such as the 5% beneficial ownership mark. Further context on whether Deep Track added to or trimmed its position will depend on the figures in the amended document.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Shattuck Labs, Inc., Deep Track Capital, LP